SCLX - Scilex Holding Co

4.61
-0.300   -6.508%

Share volume: 113,148
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$4.91
-0.30
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-12-2023 08-11-2023 11-14-2023 03-12-2024 05-13-2024 08-13-2024 01-17-2025
Total revenue 10.582 M 12.582 M 10.117 M 13.462 M 10.884 M 16.370 M 14.436 M
Cost of revenue 3.591 M 4.177 M 3.392 M 4.521 M 3.840 M 4.390 M 3.768 M
Gross profit 6.991 M 8.405 M 6.725 M 8.941 M 7.044 M 11.980 M 10.668 M
    20.23% -19.99% 32.95% -21.22% 70.07% -10.95%  
Operating expenses 31.437 M 30.193 M 44.503 M 26.254 M 32.386 M 26.602 M 32.083 M
Selling general and admin 28.701 M 26.989 M 40.431 M 23.520 M 29.278 M 24.598 M 29.734 M
Research and development 2.736 M 3.204 M 4.072 M 2.734 M 3.108 M 2.004 M 2.349 M
Total expenses 36.055 M 35.396 M 48.922 M 31.801 M 37.253 M 27.603 M 30.585 M
    -1.83% 38.21% -35.00% 17.14% -25.90% 10.80%  
Operating income -25.473 M -22.814 M -38.805 M -18.339 M -26.369 M -15.623 M -19.917 M
Ebit -25.473 M -22.814 M -38.805 M -18.339 M -26.369 M -37.011 M -3.812 M
Pretax income -30.745 M -26.652 M -35.529 M -21.392 M -24.377 M -37.582 M -4.388 M
    -13.31% 33.31% -39.79% 13.95% 54.17% -88.32%  
Income tax 8.000 K -3.000 K 0.000 8.000 K 0.000 0.000 0.000
Net income basic -30.753 M -26.649 M -35.529 M -21.400 M -24.377 M 0.000 0.000
    13.35% -33.32% 39.77% -13.91% 100.00%    
Net income -30.753 M -26.649 M -35.529 M -21.400 M -24.377 M -37.582 M -4.388 M
    13.35% -33.32% 39.77% -13.91% -54.17% 88.32%